Pharmaceuticals quality assurance

Goel R. K., Bhatt J. K., Saini V, T. Mehandiratta


Safe and effective medicines of high quality are required for
treatment of diseases. Due to unfamiliar processes, unknown
additives, adulteration and substitution without scientific proof,
many tragic deaths have happened. Due to thalidomide case in
Germany many birth defects and abnormalities have occurred.
Due to diethylene glycol poisoning of sulfanilamide elixir, many
children died. Similarly in India poisoning of gripe water with toxic
preservative has caused many deaths. Hence prior proof of
medicine is established by clinical trials. Quality control
department plays important role for assuring safety and purity of
Pharmaceutical products. Quality may be defined according to ISO as the totality of features and characteristics of a product or
service that bear on its ability to satisfy stated or implied needs.
Quality is the desire of the customer. Loss of quality means the loss of customer satisfaction, loss of public health and loss of the organization's resources. This is a prime business parameter and from time to time the concept and process of quality have changed depending on the prevailing market environment. Quality is an outcome of a quality culture in a business organization it cannot be achieved only by technical application. Quality culture means prevention and elimination of errors, waste, reworks etc.

Full Text:







INTERNATIONAL JOURNAL OF GREEN PHARMACY (Volume 1, Issue 1, April - June, 2007)

l USP the official compendia of standard, first Annual

Edition 2002, Page 77.

l Encyclopedia of Pharmaceutical technology third edition.

Volume No. 3, edited by James swarbrick, James C.

Boylan Marcel Dekkar, I. C. Page No. 2101.

l "Pharmaceutical product development", N. K. Jain, New

Delhi, Page No. 194.

l S. P. Vyas & R. K. Khar, “Targeted and Controlled drug

delivery” Novel carrier systems, CBS publishers &

distributors, New Delhi, Page NO. 111.

l Textbook of therapeutics Drug and disease management,

seventh edition, Eric T. Herfindal Dick. N. Page No.

l British Pharmacoapia Vol. 1, Page NO. 651 (1993).

l Harry G. Britain, Analytical profile of drug substance and

excipient volume No. 24, Page No. 568.

l Harry G. Britain, Analytical profile of drug substance and

excipients, volume No. 24, Page No. 523.

l Lachman L., et al, the Theory and practice of industrial

pharmacy, third edition, Page No. 297.

l Pharmaceutical Dosage form Tablet Vol. 1 second edition,

revised and expanded. Edited by Herbert A., Liberman,

Leonlachman and Joseph B. Schwartz, Page No. 195.

l Enclopedia of pharmaceutical technology second edition.

Vol. 3, edited by James Swarbrick, Jomes C. Boylan

Marcel Deker, I. C., Page. No. 2723.

l Physical Pharmacy, fourth edition Alfred martin, Indent

National student Edition, Page No. 432 (2001).

l Synopsis for Pharmacy “Gate” by Sanjay Gupta & Munish

Ahuja, Piyush Publication Pvt. Ltd., Page No. 320 (2001).



  • There are currently no refbacks.